7 employees
Dianomi Therapeutics company focused on developing treatments for inflammatory diseases, initially targeting osteoarthritis (OA).
2017
$3M
from 1 investors over 1 rounds
Dianomi Therapeutics raised $3M on February 5, 2019
Investors: Pharmacopeia now Ligand Pharmaceuticals